Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812890 · ClinicalTrials.gov registry record · Phase 1
Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 400
- Enrollment target
NCT00812890: Completed Phase 1 study, sponsored by Stanford University.
NCT00812890 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 400 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (567% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00812890, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 400 participants
- Enrollment target
Study Summary
This study will examine the feasibility, practicality, utility and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) recently approved by the food and drug administration (FDA) for both Professional (physician office) and over-the-counter (consumer) use. The study seeks to: 1. Assess the correlation of this pregnancy test results with serum values (as distinct from urine) hCG. 2. Assess whether or not time of day of urine collection has any impact on the outcome of the dBest test. 3. Assess user comprehension of the pregnancy test, especially assessment of the result.
Interventions
- DEVICE semi-quantitative pregnancy test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
What the finished NCT00812890 record still lists
NCT00812890 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (567% higher).
The record links to 0 conditions, and to 1 intervention - of which semi-quantitative pregnancy test is the first listed.
NCT00812890 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00812890 about?
NCT00812890 is a clinical study titled "Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision". This study will examine the feasibility, practicality, utility and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) recently approved by the food and drug administration (FDA) for both Professional (physician office) and over-the-counter (consumer) use. The s...
What is the current status of trial NCT00812890?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 400 participants. The study started on 2008-11. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00812890?
The interventions under investigation include: semi-quantitative pregnancy test (DEVICE).
Who is sponsoring clinical trial NCT00812890?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00812890's enrollment target sits among peer trials
400 75th of 2000 higher than 1,924 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia